Chief Financial Officer Nick Keher said the company delivered revenue growth ahead of its initial guidance despite what he ...

Oxford Nanopore Technologies (LON:ONT) outlined progress in expanding its nanopore-based sequencing platform and highlighted ...

Dan Jones and co discuss Christmas updates from the pub cos, rental reforms & the latest on one of 2021’s IPOs ...

Oxford Nanopore Technologies has signed a partnership with artificial intelligence developer SeqOne to support its next-generation sequencing approach in clinical diagnostic testing. The goal will be ...

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic ("IVD") device in the UK and Europe: the GridION (TM) Dx.

This innovative company's stock price marched higher today in the FTSE 250 index. Might this be my first Stocks and Shares ...

There are 11 million sepsis-related deaths every year, accounting for one in five deaths worldwide, according to the World Health Organization (WHO). In these severe infections, the risk of mortality ...

Oxford Nanopore Technologies PLC ( ($GB:ONT) ) has provided an update. Oxford Nanopore Technologies has issued 190,696 new ordinary shares ...

Shares in Oxford Nanopore Technologies surged in early trading on Monday, after the FTSE 250 firm said full-year sales had ...

OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK ...

It was noticeable that growth was evenly spread across its core markets, with constant currency revenue growth increasing by ...

Investing.com -- Oxford Nanopore Technologies on Monday said it expects full-year revenue to come in slightly above its guidance range after reporting about 22% growth in 2025.